The Cancer Society says it was nonsense for Pharmac to suggest the research behind Keytruda was a reason not to fund the drug. We talk to the society's medical director, Chris Jackson.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
